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SCIENTIFIC OPINION 
Scientific Opinion on Flavouring Group Evaluation 65, Revision 1 
(FGE.65Rev1): Consideration of sulfur-substituted furan derivatives used 
as flavouring agents evaluated by JECFA (59th meeting) structurally 
related to a subgroup of substances within the group of ‘Furfuryl and furan 
derivatives with and without additional side-chain substituents and 
heteroatoms from chemical group 14’ evaluated by EFSA in FGE.13Rev2 
(2011)
1
 
EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
(CEF)
2, 3
 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT  
The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids of the European Food Safety 
Authority was requested to consider evaluations of flavouring substances assessed since 2000 by the Joint 
FAO/WHO Expert Committee on Food Additives (the JECFA), and to decide whether further evaluation is 
necessary, as laid down in Commission Regulation (EC) No 1565/2000.  The substances are evaluated through a 
stepwise approach that integrates information on structure-activity relationships, intake from current uses, 
toxicological threshold of concern, and available data on metabolism and toxicity. FGE.65 concerns a group of 
33 sulfur-substituted furan derivatives evaluated by the JECFA at their 59th meeting. The Panel concluded in 
FGE.65 that the evaluation could not be finalised for four of the 33 substances [FL-no: 13.056, 13.160, 13.193 
and 13.194] due to lack of toxicity data. In the present revision of FGE.65, the toxicity data requested in FGE.65 
for [FL-no: 13.160] have now become available. These toxicity data are also considered to cover the evaluation 
of [FL-no: 13.193 and 13.194], but not [FL-no: 13.056]. Based on the new data the Panel agrees with the JECFA 
conclusion, ‘No safety concern at estimated levels of intake as flavouring substances’ based on the MSDI 
approach for 32 of the furan derivatives. For one substance [FL-no: 13.056] a request for additional toxicity data 
still remains. Besides the safety assessment of these flavouring substances, the specifications for the materials of 
commerce have also been considered and for all 33 substances, the information is adequate. 
© European Food Safety Authority, 2015 
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SUMMARY  
Following a request from the European Commission, the EFSA Panel on Food Contact Materials, 
Enzymes, Flavourings and Processing Aids (CEF Panel) was asked to deliver scientific advice to the 
Commission on the implications for human health of chemically defined flavouring substances used in 
or on foodstuffs in the Member States. In particular, the CEF Panel was requested to consider the Joint 
FAO/WHO Expert Committee on Food Additives (the JECFA) evaluations of flavouring substances 
assessed since 2000, and to decide whether no further evaluation is necessary, as laid down in 
Commission Regulation (EC) No 1565/2000. These flavouring substances are listed in the Register, 
which was adopted by Commission Decision 1999/217/EC and its consecutive amendments. 
The present evaluation deals with 33 substances in the JECFA flavouring group of sulfur-substituted 
furan derivatives. These substances are structurally related to the group of sulfur-substituted furans 
evaluated within the group of ‘Furfuryl and furan derivatives with and without additional side-chain 
substituents and heteroatoms from chemical group 14’ evaluated by EFSA in Flavouring Group 
Evaluation 13, Revision 2 (FGE.13Rev2).  
The present revision of FGE.65, FGE.65Rev1 is due to the availability of new toxicity data on 2-
methyltetrahydrofuran-3-thiol [FL-no: 13.160], requested by the Panel in FGE.65. 
The Panel agrees with the way the application of the Procedure has been performed by the JECFA for 
32 candidate substances included in this FGE. For 23 substances the Panel also agreed with JECFA 
with respect to the choice of the NOAEL to finalise the evaluation. For nine substances the NOAEL 
used by JECFA was considered invalid, but the Panel could finalise the evaluations of these 
substances using NOAELs derived from new or existing data from the candidate substances or for 
supporting substances. Thus, for 32 substances the Panel reached the same conclusion as JECFA with 
respect to their use as chemically defined flavouring substances in food. For one substance [FL-no: 
13.056] no adequate NOAEL could be identified by the Panel and subsequently, no conclusion as to 
the safety when used at levels of intake estimated using the MSDI approach could be reached.  
For all 33 substances evaluated through the Procedure by the JECFA use levels are needed to calculate 
the Modified Theoretical Added Maximum Daily Intake (mTAMDI) in order to identify those 
flavouring substances that need more refined exposure assessment and to finalise the evaluation.  
In order to determine whether the conclusion for the 33 JECFA evaluated substances can be applied to 
the materials of commerce, it is necessary to consider the available specifications: Adequate 
specifications including complete purity criteria and identity are available for all of the JECFA- 
evaluated substances. 
Thus, the Panel has reservations for one substance [FL-no: 13.056] for which additional toxicity data 
are needed. For the remaining 32 JECFA-evaluated sulfur-substituted furan derivatives [Fl-nos: 
13.015, 13.016, 13.017, 13.026, 13.032, 13.033, 13.040, 13.041, 13.050, 13.051, 13.053, 13.055, 
13.056, 13.063, 13.064, 13.071, 13.075, 13.077, 13.078, 13.079, 13.082, 13.086, 13.093, 13.142, 
13.151, 13.152, 13.153, 13.160, 13.193, 13.194, 13.196 and 13.197], the Panel agrees with JECFA 
conclusion ‘No safety concern at estimated levels of intake as flavouring substances’ based on the 
MSDI approach.  
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
The use of flavourings is regulated under Regulation (EC) No 1334/2008 of the European Parliament 
and Council of 16 December 2008
4
 on flavourings and certain food ingredients with flavouring 
properties for use in and on foods. On the basis of Article 9(a) of this Regulation, an evaluation and 
approval are required for flavouring substances. 
The Union list of flavourings and source materials was established by Commission Implementing 
Regulation (EC) No 872/2012
5
. The list contains flavouring substances for which the scientific 
evaluation should be completed in accordance with Commission Regulation (EC) No 1565/2000
6
. 
On 25 November 2009, the EFSA Panel on Food Contact Materials, Enzymes, Flavourings and 
Processing Aids (CEF) adopted an opinion on Flavouring Group Evaluation 65 (FGE.65): 
consideration of sulfur-substituted furan derivatives used as flavouring agents evaluated by JECFA 
(59th meeting) structurally related to a subgroup of substances within the group of ‘furfuryl and furan 
derivatives with and without additional side-chain substituents and heteroatoms from chemical group 
14’ evaluated by EFSA in FGE.13Rev1 (2009)7. 
In its opinion, the Panel stated that, ‘for the flavouring substances [FL-no: 13.160, 13.193 and 13.194] 
no adequate NOAEL could be identified and subsequently, no conclusion as to the safety when used at 
levels of intake estimated using the MSDI approach could be reached’. 
Also, information on the isomeric composition / composition of mixture has not been specified for 
these substances.’ 
Thus, the Panel had reservations for these substances: data on the stereoisomeric composition / 
composition of the mixture has not been specified and additional toxicity data are needed. 
On 23 January 2014, the European Flavour Association (EFFA) submitted the requested data. 
Regarding the submitted 90-day oral (gavage) toxicity study, the applicant stipulates that, although 
EFSA had indicated 2,5-dimethyltetrahydro-3-furylthio acetate [FL-no: 13.194] as the ‘representative 
substance’,8 2-methyltetrahydrofuran-3-thiol [FL-no: 13.160] was selected by the applicant as the 
alternative representative substance, because of its much higher commercial relevance and because it 
was much more easily to procure a sufficient amount of standard material. 2,5-Dimethyltetrahydro-3-
furylthio acetate [FL-no: 13.194] has a rather low commercial relevance compared to [FL-no: 13.160] 
and consequently, the low volume of use makes it difficult to obtain a sufficient amount of sample for 
testing.  
In addition, the applicant draws attention to the structural similarities between the selected 
representative for testing and the material originally selected by EFSA: 
 EFSA had selected an ester, which upon hydrolysis yield the corresponding alcohol. Thus 
from a metabolic point of view, both materials (ester or alcohol) will have the same fate. 
                                                     
4  Regulation (EC) No 1334/2008 of the European Parliament and of the Council of 16 December 2008 on flavourings and 
certain food ingredients with flavouring properties for use in and on foods and amending Council Regulation (EEC) No 
1601/91, Regulations (EC) No 2232/96 and (EC) No 110/2008 and Directive 2000/13/EC. OJ L 354, 31.12.2008, p. 34-50. 
5  Commission implementing Regulation (EU) No 872/2012 of 1 October 2012 adopting the list of flavouring substances 
provided for by Regulation (EC) No 2232/96 of the European Parliament and of the Council, introducing it in Annex I to 
Regulation (EC) No 1334/2008 of the European Parliament and of the Council and repealing Commission Regulation (EC) 
No 1565/2000 and Commission Decision 1999/217/EC. OJ L 267, 2.10.2012, p, 1-161. 
6  Commission Regulation No 1565/2000 of 18 July 2000 laying down the measures necessary for the adoption of an 
evaluation programme in application of Regulation (EC) No 2232/96. OJ L 180, 19.7.2000, p. 8-16. 
7  EFSA Journal 2010;8(7):1406 
8  EFSA Journal 2012;10(3):2639 
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 The other difference between the alternative representative substance and the substance 
selected by EFSA is the substitution pattern: although the selected (tested) representative 
substance, 2-methyltetrahydrofuran-3-thiol has only one methylgroup and the originally 
indicated representative substance has two methyl substituents, both molecules are structurally 
very similar and both substances are expected to participate in common routes of absorption, 
distribution, and metabolic detoxication, and exhibit similar toxicological properties. 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION  
The European Commission requests the European Food Safety Authority (EFSA) to evaluate this new 
information and, depending on the outcome, proceed to the full evaluation on these flavouring 
substances in accordance with Commission Regulation (EC) No 1565/2000. 
Flavouring Group Evaluation 65 Revision 1 
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ASSESSMENT 
The approach used by EFSA for safety evaluation of flavouring substances is referred to in 
Commission Regulation (EC) No 1565/2000, hereafter named the ‘EFSA Procedure’. This Procedure 
is based on the Opinion of the Scientific Committee on Food (SCF, 1999), which has been derived 
from the evaluation procedure developed by the Joint FAO/WHO Expert Committee on Food 
Additives (JECFA, 1995; JECFA, 1996; JECFA, 1997; JECFA, 1999), hereafter named the ‘JECFA 
Procedure’. The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (the 
Panel) compares the JECFA evaluation of structurally related substances with the result of a 
corresponding EFSA evaluation, focussing on specifications, intake estimations and toxicity data, 
especially genotoxicity data. The evaluations by EFSA will conclude whether the flavouring 
substances are of no safety concern at their estimated levels of intake, whether additional data are 
required or whether certain substances should not be evaluated through the EFSA Procedure. 
The following issues are of special importance. 
Intake 
In its evaluation, the Panel as a default uses the Maximised Survey-derived Daily Intake (MSDI) 
approach to estimate the per capita intakes of the flavouring substances in Europe.  
In its evaluation, the JECFA includes intake estimates based on the MSDI approach derived from both 
European and USA production figures. The highest of the two MSDI figures is used in the evaluation 
by the JECFA. It is noted that in several cases, only the MSDI figures from the USA were available, 
meaning that certain flavouring substances have been evaluated by the JECFA only on the basis of 
these figures. For Register substances for which this is the case the Panel will need EU production 
figures in order to finalise the evaluation. 
When the Panel examined the information provided by the European Flavour Industry on the use 
levels in various foods, it appeared obvious that the MSDI approach in a number of cases would 
grossly underestimate the intake by regular consumers of products flavoured at the use level reported 
by the Industry, especially in those cases where the annual production values were reported to be 
small. In consequence, the Panel had reservations about the data on use and use levels provided and 
the intake estimates obtained by the MSDI approach. It is noted that the JECFA, at its 65th meeting 
considered ‘how to improve the identification and assessment of flavouring agents, for which the 
MSDI estimates may be substantially lower than the dietary exposures that would be estimated from 
the anticipated average use levels in foods’ (JECFA, 2006). 
In the absence of more accurate information that would enable the Panel to make a more realistic 
estimate of the intakes of the flavouring substances, the Panel has decided also to perform an estimate 
of the daily intakes per person using a modified Theoretical Added Maximum Daily Intake 
(mTAMDI) approach based on the normal use levels reported by Industry. 
As information on use levels for the flavouring substances has not been requested by the JECFA or 
has not otherwise been provided to the Panel, it is not possible to estimate the daily intakes using the 
mTAMDI approach for the substances evaluated by the JECFA. The Panel will need information on 
use levels in order to finalise the evaluation. 
Threshold of 1.5 microgram/person per day (Step B5) used by the JECFA 
The JECFA uses the threshold of concern of 1.5 microgram (µg)/person per day as part of the 
evaluation procedure: 
‘The Committee noted that this value was based on a risk analysis of known carcinogens which 
involved several conservative assumptions. The use of this value was supported by additional 
information on developmental toxicity, neurotoxicity and immunotoxicity. In the judgement of the 
Flavouring Group Evaluation 65 Revision 1 
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Committee, flavouring substances for which insufficient data are available for them to be evaluated 
using earlier steps in the Procedure, but for which the intake would not exceed 1.5 µg per person per 
day would not be expected to present a safety concern. The Committee recommended that the 
Procedure for the Safety Evaluation of Flavouring Agents used at the forty-sixth meeting be amended 
to include the last step on the right-hand side of the original procedure (‘Do the condition of use result 
in an intake greater than 1.5 µg per day?’)’ (JECFA, 1999).  
In line with the Opinion expressed by the Scientific Committee on Food (SCF, 1999), the Panel does 
not make use of this threshold of 1.5 µg per person per day. 
Genotoxicity 
As reflected in the Opinion of SCF (SCF, 1999), the Panel has in its evaluation focussed on a possible 
genotoxic potential of the flavouring substances or of structurally related substances. Generally, 
substances for which the Panel has concluded that there is an indication of genotoxic potential in vitro, 
will not be evaluated using the EFSA Procedure until further genotoxicity data are provided. 
Substances for which a genotoxic potential in vivo has been concluded, will not be evaluated through 
the Procedure. 
Specifications 
Regarding specifications, the evaluation by the Panel could lead to a different opinion than that of 
JECFA, since the Panel requests information on e.g. isomerism. 
Structural Relationship  
In the consideration of the JECFA evaluated substances, the Panel will examine the structural 
relationship and metabolism features of the substances within the flavouring group and compare this 
with the corresponding FGE. 
1. History of the evaluation of the substances in the present FGE  
In FGE.65, which covered a group of 33 JECFA-evaluated flavouring substances consisting of sulfur-
substituted furan derivatives (JECFA, 2003), the Panel concluded that no NOAEL could be derived for 
the four substances [FL-no: 13.056, 13.160, 13.193 and 13.194] or for structurally related substances. 
Accordingly, additional toxicity data were required for these substances. 
FGE Opinion adopted Link No. of substances 
FGE.65 25 November 2009 http://www.efsa.europa.eu/en/scdocs/scdoc/
1406.htm 
33 
FGE.65Rev1 19 January 2015  33 
 
The present revision of FGE.65 (FGE.65Rev1) concerns a reconsideration of three substances [FL-no: 
13.160, 13.193 and 13.194], based on additional toxicity data. A 14 day palatability and range finding 
study followed by a 90-day dietary study, have now been provided for 2-methyltetrahydrofuran-3-thiol 
[FL-no: 13.160]. This substance is considered representative for [FL-no: 13.193 and 13.194]. 
Furthermore, for these three substances [FL-no: 13.160, 13.193 and 13.194] information on the 
composition of the stereoisomeric mixture has been provided. 
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2. Presentation of the substances in the JECFA Flavouring Group 
2.1. Description 
2.1.1. JECFA status 
At its 59th meeting the JECFA (JECFA, 2002a) concluded the following:  
‘The Committee concluded that use of flavouring agents in this group of 33 thiofurfuryl and thiofuran 
derivatives at current levels of intake would not present a safety concern. In the Procedure, data on 
toxicity were required for all the evaluations. The Committee noted the absence of data on the 
metabolic fate of these substances but considered that their potential metabolism via the reactive 
divalent sulfur atom and their very low levels of use as flavouring agents were consistent with the 
outcome of the evaluations.’ 
These 33 substances evaluated at the 59th JECFA meeting have been presented in Table 1. 
2.1.2. EFSA considerations 
The Panel concluded that all the substances in the JECFA flavouring group of sulfur-substituted furan 
derivatives are structurally related to a group of sulfur-containing furane derivatives evaluated within 
the group of ‘Furfuryl and furan derivatives with and without additional side-chain substituents and 
heteroatoms from chemical group 14 evaluated by EFSA in the Flavouring Group Evaluation 13, 
Revision 2 (FGE.13Rev2; (EFSA CEF Panel, 2011). 
This group of flavouring substances is very diverse with respect to their chemical structures and in 
acconcordance with the approach followed in FGE.13Rev2 (EFSA CEF Panel, 2011) the group has 
been subdivided into five subgroups (see Table 1). Because of lack of data on metabolism on 
candidate or supporting substances in FGE.13Rev2, the metabolism of these FGE.13 substances has 
been evaluated by comparison with information on the metabolism of other (non-furan) sulfur-
containing substances in FGE.08Rev5 (EFSA CEF Panel, 2012). It was decided that the sulfur-
containing furan candidate substances in FGE.13Rev2 could not be anticipated to be metabolised to 
innocuous products and therefore these substances were evaluated via the B-side of the Procedure. The 
same approach has been followed by the JECFA at its 59th meeting (JECFA, 2002a). 
Table 1:  Grouping of 33 thiofurfuryl and thiofuran derivatives evaluated by the JECFA 
FL-no 
JECFA-no 
EU Register name Structural formula 
Ia Sulphides 
13.053 
1076 
Methyl furfuryl sulfide S
O
 
13.065 
1062 
2-Methyl-5-(methylthio)furan 
O S
 
13.152 
1061 
2-Methyl-3-(methylthio)furan 
O
S  
13.196 
1084 
4-[(2-Furanylmethyl)thio]-2-pentanone 
O
S
O
 
13.032 
1077 
Furfuryl isopropyl sulfide 
O
S
 
13.056 
1080 
Difurfuryl sulfide9 S
O
O
 
                                                     
9 The Commission has communicated that this substance is in the process of being deleted from the Union List. 
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Table 1:  Grouping of 33 thiofurfuryl and thiofuran derivatives evaluated by the JECFA 
FL-no 
JECFA-no 
EU Register name Structural formula 
13.075 
1086 
2,6-Dimethyl-3-((2-methyl-3-furyl)thio)heptan-4-one 
O
S
O
 
13.077 
1085 
3-((2-Methyl-3-furyl)thio)heptan-4-one 
O
S
O
 
13.078 
1087 
4-((2-Methyl-3-furyl)thio)nonan-5-one 
O
S
O
 
13.093 
1088 
Ethyl 3-(2-furfurylthio)propionate 
OS
O
O
 
13.151 
1082 
2-Methyl-3,5 and 6-(furfurylthio)pyrazine 
2 or 5 or 6 -Methyl-3-(furfurylthio)pyrazine
N
N
S
O
 
Ib Thiols 
13.026 
1072 
2-Furanmethanethiol 
O
SH
 
13.055 
1060 
2-Methylfuran-3-thiol 
O
SH  
13.071 
1063 
2,5-Dimethylfuran-3-thiol 
O
SH  
13.160 
1090 
2-Methyltetrahydrofuran-3-thiol 
O
SH  
13.193 
1091 
2,5-Dimethyltetrahydro-3-furanthiol 
O
SH  
Ic Disulphides 
13.016 
1066 
bis-(2-Methyl-3-furyl) disulfide 
O
S
S
O
 
13.050 
1081 
Difurfuryl disulfide 
S
SO
O
 
13.064 
1078 
Methyl furfuryl disulfide S
SO
 
13.082 
1065 
Propyl 2-methyl-3-furyl disulfide 
O
S
S
 
13.079 
1064 
Methyl 2-methyl-3-furyl disulfide 
O
S
S
 
13.197 
1079 
Furfuryl propyl disulfide O
S
S
 
13.015 
1067 
bis-(2,5-Dimethyl-3-furyl) disulfide 
O
S
S
O
 
Id Polysulphides 
13.017 
1068 
bis-(2-Methyl-3-furyl) tetrasulfide 
S
SS
S
O
O
 
Ie Thioester 
13.033 
1074 
S-Furfuryl acetothioate 
O
S
O
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Table 1:  Grouping of 33 thiofurfuryl and thiofuran derivatives evaluated by the JECFA 
FL-no 
JECFA-no 
EU Register name Structural formula 
13.153 
1069 
2-Methyl-3-furyl thioacetate 
O
S
O
 
13.040 
1071 
S-2,5-Dimethyl-3-thiofuroylfuran 
O
S
O
O
 
13.041 
1070 
2,5-Dimethyl-3-(isovalerylthio)furan 
O
S
O
 
13.051 
1073 
S-Furfuryl thioformate 
O
S O
 
13.063 
1075 
S-Furfuryl propanethioate 
O
S
O
 
13.086 
1089 
4,5-Dihydro-2-methyl-3-thioacetoxyfuran 
O
S
O
 
13.142 
1083 
S-Methyl 2-furanthiocarboxylate 
O
S
O
 
13.194 
1092 
2,5-Dimethyltetrahydro-3-furyl thio acetate 
O
S
O
 
 
2.2. Isomers 
2.2.1. Status 
The following substances [FL-no: 13.075, 13.077, 13.078, 13.160, 13.193, 13.194 and 13.196] in the 
group of the JECFA-evaluated sulfur substituted furan derivatives have one or more chiral centres. 
2.2.2. EFSA considerations 
For the seven substances, listed in Section 2.2.1, the configurations of the chiral centres have been 
specified and information is available on the compositions of the stereoisomeric mixtures. 
2.3. Specifications 
2.3.1. Status 
The JECFA specifications are available for all 33 substances (JECFA, 2002b). See Table 2. 
2.3.2. EFSA considerations 
The available specifications are considered adequate for all 33 substances (see Section 2.2). 
3. Intake estimation 
3.1. Status 
For all 33 substances evaluated through the JECFA Procedure production volumes, based on which 
MSDI values can be calculated, are available for the EU, see Table 4. 
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SUMMARY OF SPECIFICATION DATA 
Table 2:  Specification Summary of the Substances in the JECFA Flavouring Group (JECFA, 2002b) 
FL-no 
JECFA
-no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility(a) 
Solubility in 
ethanol(b) 
Boiling point, °C(c) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index(d) 
Spec.gravity(e) 
EFSA comments 
13.015 
1067 
bis-(2,5-Dimethyl-3-
furyl) disulfide 
O
S
S
O
 
3476 
722 
28588-73-0 
Liquid 
C12H14O2S2 
254.38 
Insoluble 
Miscible 
110-111 (1 hPa) 
 
IR NMR 
99 % 
1.548-1.568 
1.140-1.152 
 
 
13.016 
1066 
bis-(2-Methyl-3-
furyl) disulfide 
O
S
S
O
 
3259 
723 
28588-75-2 
Liquid 
C10H10O2S2 
226.31 
Insoluble 
Miscible 
84-85 (0.4 hPa) 
 
NMR 
98 % 
1.572-1.583 
1.146-1.154 
 
 
13.017 
1068 
bis-(2-Methyl-3-
furyl) tetrasulfide 
O
OS
S
S
S
 
3260 
724 
28588-76-3 
Liquid 
C10H10O2S4 
290.43 
Insoluble 
Slightly 
soluble 
142-147 (1 hPa) 
 
NMR 
96 % 
1.671-1.693 
1.366-1.378 
 
 
13.026 
1072 
2-Furanmethanethiol O
SH
 
2493 
2202 
98-02-2 
Liquid 
C5H6OS 
114.16 
Insoluble 
Miscible 
154-155 
 
NMR 
97 % 
1.527-1.542 
1.125-1.135 (20°) 
 
 
13.032 
1077 
Furfuryl isopropyl 
sulfide O
S
 
3161 
2248 
1883-78-9 
Liquid 
C8H12OS 
156.24 
Insoluble 
Miscible 
84 (21 hPa) 
 
NMR 
97 % 
1.497-1.508 
1.013-1.020 (20°) 
 
 
13.033 
1074 
S-Furfuryl 
acetothioate O
S
O
 
3162 
2250 
13678-68-7 
Liquid 
C7H8O2S 
156.20 
Insoluble 
Miscible 
90-92 (16 hPa) 
 
NMR 
95 % 
1.522-1.529 
1.149-1.155 (20°) 
 
 
13.040 
1071 
(S)-2,5-Dimethyl-3-
thiofuroylfuran 
O
O
S
O
 
3481 
2323 
65505-16-0 
Liquid 
C11H10O3S 
222.26 
Insoluble 
Miscible 
79-83 (0.9 hPa) 
 
IR NMR 
98 % 
1.512-1.519 
1.047-1.058 
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Table 2:  Specification Summary of the Substances in the JECFA Flavouring Group (JECFA, 2002b) 
FL-no 
JECFA
-no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility(a) 
Solubility in 
ethanol(b) 
Boiling point, °C(c) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index(d) 
Spec.gravity(e) 
EFSA comments 
13.041 
1070 
2,5-Dimethyl-3-
(isopentylthio)furan 
O
S
O
 
3482 
2324 
55764-28-8 
Liquid 
C11H16O2S 
212.31 
Insoluble 
Miscible 
124-125 (8 hPa) 
 
IR NMR 
99 % 
1.492-1.508 
1.025-1.034 
Registername to be 
changed to 2,5-
dimethyl-3-
(isovalerylthio)furan. 
13.050 
1081 
Difurfuryl disulfide 
S
SO
O
 
3146 
11480 
4437-20-1 
Liquid 
C10H10O2S2 
226.31 
Slightly 
soluble 
Miscible 
229-230 
 
NMR 
96 % 
1.585-1.598 
1.229-1.248 
 
 
13.051 
1073 
S-Furfuryl 
thioformate 
O
S O
 
3158 
11770 
59020-90-5 
Liquid 
C6H6O2S 
142.17 
Insoluble 
Miscible 
80-87 (13 hPa) 
 
NMR 
97 % 
1.539-1.549 
1.213-1.223 (20°) 
 
 
13.053 
1076 
Methyl furfuryl 
sulfide 
S
O
 
3160 
11482 
1438-91-1 
Liquid 
C6H8OS 
128.19 
Insoluble 
Miscible 
62-63 (36 hPa) 
 
NMR 
97 % 
1.518-1.530 
1.082-1.089 (20°) 
 
 
13.055 
1060 
2-Methylfuran-3-
thiol 
O
SH  
3188 
11678 
28588-74-1 
Liquid 
C5H6OS 
114.16 
Insoluble 
Miscible 
57-60 (57 hPa) 
 
NMR 
95 % 
1.509-1.530 
1.141-1.150 
According to JECFA: 
Min. assay value is 
‘95’ and secondary 
components ‘Bis(2-
methyl-3-
furyl)disulfide’. 
13.056 
1080 
Difurfuryl sulfide 
S
OO
 
3238 
11438 
13678-67-6 
Liquid 
C10H10O2S 
194.25 
Insoluble 
Miscible 
135-143 (18hPa) 
 
NMR 
95 % 
1.545-1.560 
1.144-1.154 
 
 
13.063 
1075 
S-Furfuryl 
propanethioate 
O
S
O
 
3347 
11484 
59020-85-8 
Liquid 
C8H10O2S 
170.23 
Insoluble 
Miscible 
95-97 (13 hPa) 
 
NMR 
97 % 
1.506-1.521 
1.089-1.111 (20°) 
 
 
13.064 
1078 
Methyl furfuryl 
disulfide 
S
SO
 
3362 
11513 
57500-00-2 
Liquid 
C6H8OS2 
160.25 
Insoluble 
Miscible 
102-103.5(30hPa 
 
NMR 
95 % 
1.565-1.573 
1.177-1.184 (20°) 
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Table 2:  Specification Summary of the Substances in the JECFA Flavouring Group (JECFA, 2002b) 
FL-no 
JECFA
-no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility(a) 
Solubility in 
ethanol(b) 
Boiling point, °C(c) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index(d) 
Spec.gravity(e) 
EFSA comments 
13.065 
1062 
2-Methyl-5-
(methylthio)furan 
O S
 
3366 
11550 
13678-59-6 
Liquid 
C6H8OS 
128.19 
Insoluble 
Miscible 
66-67 (30 hPa) 
 
NMR 
98 % 
1.514-1.520 
1.055-1.059 (20°) 
 
 
13.071 
1063 
2,5-Dimethylfuran-
3-thiol 
O
SH  
3451 
11457 
55764-23-3 
Liquid 
C6H8OS 
128.19 
Insoluble 
Miscible 
70 (39 hPa) 
 
IR 
98 % 
1.500-1.520 
1.138-1.144 
 
 
13.075 
1086 
2,6-Dimethyl-3-((2-
methyl-3-
furyl)thio)heptan-4-
one 
O
S
O  
3538 
11915 
61295-51-0 
Liquid 
C14H22O2S 
254.39 
Insoluble 
Miscible 
90-92 (0.3 hPa) 
 
IR NMR 
94 % 
1.488-1.494 
1.006.1.022 
Racemate (EFFA, 
2010a). According to 
JECFA: Min. Assay 
value is ‘94’ and 
secondary components 
‘2,6-Dimethyl-2-[(2-
methyl-3-furyl)thio]-
4-heptanone’. 
13.077 
1085 
3-((2-Methyl-3-
furyl)thio)heptan-4-
one 
O
S
O  
3570 
11922 
61295-41-8 
Liquid 
C12H18O2S 
226.33 
Insoluble 
Miscible 
85-86 (0.4 hPa) 
 
IR NMR 
97 % 
1.496-1.502 
1.041-1.045 
Racemate (EFFA, 
2010a). 
13.078 
1087 
4-((2-Methyl-3-
furyl)thio)nonan-5-
one 
O
S
O
 
3571 
11923 
61295-50-9 
Liquid 
C14H22O2S 
254.39 
Insoluble 
Miscible 
102-103(0.3hPa) 
 
IR NMR 
98 % 
1.489-1.496 
1.000-1.012 
Racemate (EFFA, 
2010a). 
13.079 
1064 
Methyl 2-methyl-3-
furyl disulfide 
O
S
S
 
3573 
11924 
65505-17-1 
Liquid 
C6H8OS2 
160.25 
Insoluble 
Miscible 
72.5-75 (7 hPa) 
 
IR NMR 
97 % 
1.558-1.563 
1.203-1.208 
According to JECFA: 
Min. assay value is 
‘97’ and secondary 
components ‘up to 3% 
bis(2-methyl-3-
furyl)disulfide’. 
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Table 2:  Specification Summary of the Substances in the JECFA Flavouring Group (JECFA, 2002b) 
FL-no 
JECFA
-no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility(a) 
Solubility in 
ethanol(b) 
Boiling point, °C(c) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index(d) 
Spec.gravity(e) 
EFSA comments 
13.082 
1065 
Propyl 2-methyl-3-
furyl disulfide 
O
S
S
 
3607 
 
61197-09-9 
Liquid 
C8H12OS2 
188.32 
Insoluble 
Miscible 
75.5-79 (2 hPa) 
 
IR NMR 
97 % 
1.534-1.539 
1.094-1.104 
According to JECFA: 
Min. assay value is 
‘97’ and secondary 
components ‘up to 2% 
bis(2-methyl-3-
furyl)disulfide and 
propyl disulfide’.  
13.086 
1089 
4,5-Dihydro-2-
methyl-3-
thioacetoxyfuran 
O
S
O
 
3636 
 
26486-14-6 
Liquid 
C7H10O2S 
158.22 
 
Miscible 
40-42 (0.1 hPa) 
 
NMR 
99 % 
1.517-1.521 
1.132-1.139 
 
 
13.093 
1088 
Ethyl 3-(2-
furfurylthio)propiona
te OS
O
O
 
3674 
 
94278-27-0 
Liquid 
C10H14O3S 
214.28 
Insoluble 
Miscible 
244 (975 hPa) 
 
IR NMR 
97 % 
1.500-1.509 
1.121-1.138 
 
 
13.142 
1083 
S-Methyl 2-
furanthiocarboxylate O
S
O
 
3311 
11547 
13679-61-3 
Liquid 
C6H6O2S 
142.17 
Insoluble 
Miscible 
92-93 (14 hPa) 
 
NMR 
97 % 
1.567-1.573 
1.230-1.241 
 
 
13.151 
1082 
2-Methyl-3,5 and 6-
(furfurylthio)pyrazin
e 
2 or 5 or 6 -Methyl-3-(furfurylthio)pyrazine
N
N
O
S
 
3189 
2287 
65530-53-2 
Liquid 
C10H10ON2S 
206.26 
Insoluble 
Miscible 
85-87 (13 hPa) 
 
NMR 
99 % 
1.580-1.586 
1.138-1.148 (20°) 
According to JECFA: 
Min. assay value is 
‘99’ and ‘Mixture of 
isomers: 70% 2,3-; 
29% 2,6-; trace 2,5-’. 
13.152 
1061 
2-Methyl-3-
(methylthio)furan 
O
S  
3949 
 
63012-97-5 
Liquid 
C6H8OS 
128.19 
Insoluble 
Miscible 
172 
 
NMR 
95 % 
1.506-1.514 
1.064-1.071 (20°) 
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Table 2:  Specification Summary of the Substances in the JECFA Flavouring Group (JECFA, 2002b) 
FL-no 
JECFA
-no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility(a) 
Solubility in 
ethanol(b) 
Boiling point, °C(c) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index(d) 
Spec.gravity(e) 
EFSA comments 
13.153 
1069 
2-Methyl-3-furyl 
thioacetate 
O
S
O
 
 
 
55764-25-5 
Liquid 
C7H8O2S 
156.2 
Insoluble 
Miscible 
222-224 
 
NMR 
92 % 
1.444-1.451 
1.140-1.159 
2-Ethanethoic acid, S-
(2-methyl-3-furanyl) 
ester (92%), 
secondary components 
(Z)- and (E)-2-Methyl-
3-tetrahydrofuranthiol 
acetate (sum > 95%), 
(EFFA, 2010a). 
13.160 
1090 
2-
Methyltetrahydrofur
an-3-thiol 
O
SH  
3787 
 
57124-87-5 
Liquid 
C5H10OS 
118.2 
Insoluble 
Miscible 
79 (70 hPa) 
 
IR NMR MS 
97 % 
1.475-1.491 
1.042-1.049 
Mixtur of 
diastereoisomers 
(EFFA, 2010a). 
According to JECFA: 
Min. Assay value is 
‘97’ and ‘71 % trans 
and 26 % cis isomer’. 
13.193 
1091 
2,5-
Dimethyltetrahydro-
3-furanthiol 
O
SH  
3971 
 
26486-21-5 
Liquid 
C6H12OS 
132.2 
Insoluble 
Miscible 
175 
 
IR NMR MS 
96 % 
1.477-1.484 
1.040-1.048 (20°) 
Mixture of 
stereoisomers: 40-
50% 2S,3R,5R: 25-
30% 2R,3S,5S: 15-
20% 2R,3R,5S: 5-10% 
2S,3S,5R: others <5% 
(EFFA, 2015). 
According to JECFA: 
Min. Assay value is 
‘96 (mixture of 4 
stereoisomers)’. 
Composition of 
stereoisomeric 
mixture to be 
specified. 
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Table 2:  Specification Summary of the Substances in the JECFA Flavouring Group (JECFA, 2002b) 
FL-no 
JECFA
-no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility(a) 
Solubility in 
ethanol(b) 
Boiling point, °C(c) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index(d) 
Spec.gravity(e) 
EFSA comments 
13.194 
1092 
2,5-
Dimethyltetrahydro-
3-furyl thio acetate 
O
S
O
 
3972 
 
252736-39-3 
Liquid 
C8H14O2S 
174.3 
Insoluble 
Miscible 
50 (1 hPa) 
 
IR NMR MS 
90 % 
1.468-1.474 
0.933-1.003 (20°) 
Mixture of 
stereoisomers: 35-
45% 2S,3R,5R: 25-
30% 2R,3S,5S: 10-
15% 2R,3R,5S: 5-10% 
2S,3S,5R; others <5% 
(EFFA, 2015). 
According to JECFA: 
Min. Assay value is 
‘90 (mixture of 4 
stereoisomers)’ and 
secondary components 
‘2,5-
dimethyltetrahydrofur
an-3-thiol & 
dimethyltetrahydro-3-
furyl dithioacetate’. 
13.196 
1084 
4-[(2-
Furanylmethyl)thio]-
2-pentanone 
O
S
O
 
3840 
 
180031-78-1 
Liquid 
C10H14O2S 
198.29 
Insoluble 
50% Soluble 
in ethanol 
113 
 
IR MS 
97 % 
1.513-1.518 
1.088-1.096 
Racemate (EFFA, 
2010a). 
13.197 
1079 
Furyl propyl 
disulfide 
O
S
S
 
3979 
 
252736-36-0 
Liquid 
C8H12OS2 
188.29 
Insoluble 
Miscible 
121-123 (23hPa) 
 
MS 
96 % 
1.539-1.547 
1.103-1.113 (20°) 
 
 
(a): Solubility in water, if not otherwise stated. 
(b): Solubility in 95 % ethanol, if not otherwise stated. 
(c): At 1013.25 hPa, if not otherwise stated. 
(d): At 20°C, if not otherwise stated. 
(e): At 25°C, if not otherwise stated. 
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4. Genotoxicity data 
4.1. Genotoxicity studies – Text taken10 from the JECFA (JECFA, 2003) 
No data on genotoxicity were available for the JECFA-evaluated substances. 
4.2. Genotoxicity studies – Text taken11 from EFSA FGE.13Rev2 (EFSA CEF Panel, 2011) 
In vitro /in vivo 
No genotoxicity data were available on any of the 14 sulfur-containing candidate substances in main 
group II of FGE.13Rev2, nor on their related supporting substances. The lack of data does not allow to 
conclude on their potential for genotoxicity. By default, these 14 substances in main group II can be 
evaluated through the Procedure. 
4.3. EFSA considerations 
There are no genotoxicity data on candidate or supporting substances in this FGE. Therefore the 
genotoxicity of these substances cannot be properly assessed. However, this would not preclude the 
evaluation of the substances through the Procedure. 
5. New toxicity data considered by the Panel in FGE.65Rev1 
5.1. 14- and 90-day dietary study with 2-methyltetrahydrofuran-3-thiol [FL-no: 13.160] 
14-day study 
A 14-day palatability and dose-range finding study was performed with the candidate substance 2-
methyltetrahydrofuran-3-thiol [FL-no:13.160] (Kappeler, 2013). Four groups of adult Crl:CD(SD) rats 
(3/sex/group) were placed into one control and three test groups. The dietary concentrations of 
methyltetrahydrofuran-3-thiol were adjusted to obtain provisional consumptions of 0, 75, 500 and 
1000 mg/kg bw per day. A NOAEL of 75 mg/kg bw per day was identified, based on a body weight 
gain reduction in males at dose levels of 500 and 1000 mg/kg bw per day, mostly attributable to 
reduced feed intake. In the females, the difference in body weight gain did not reach statistical 
significance (N=3/sex/group). 
90-day study 
Based on the results from the 14-day study, the test substance, 2-methyltetrahydrofuran-3-thiol (purity 
97.27 %) was administered to Crl:CD(SD) rats (10/sex/dose) by gavage at doses of 0, 5, 55 and 125 
mg in corn oil/kg bw per day (Kappeler, 2014). The 90-day study has been conducted in accordance 
with the OECD Test Guideline 408 and GLP principles. In this study, the animals of the control group 
received vehicle only (corn oil). All animals were subject to daily clinical examinations and twice 
daily observed for observations for mortality and morbidity. Detailed physical examinations, including 
body weight and food consumption measurements were carried out once per week. Ophthalmic 
examinations were performed before the start of the study and in week 12. Clinical pathology 
parameters (haematology, coagulation, serum chemistry and urinalysis) were evaluated for all animals 
at the scheduled necropsy, after 90 days of treatment. Blood for haematology and serum chemistry 
was collected at necropsy after overnight fast and urine was collected overnight prior to necropsy. 
Coagulation was measured in blood collected from anesthetized animals prior to sacrifice. Selected 
organs were weighed at the time of necropsy and selected tissues were examined microscopically. All 
tissues were examined microscopically for animals of the 125 mg/kg bw per day groups. In addition, 
                                                     
10  The text is taken verbatim from the indicated reference source, but text related to substances not included in the present 
FGE has been removed. 
11  The text is taken verbatum from the indicated reference source, but text related to subgroups not included in the present 
FGE has been removed. 
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all tissues showing pathological changes that might be attributable to the testing substance in the top 
dose group were also examined for all animals of the two lower intake level groups. 
All but one male and one female animal of the high dose group survived to the end of the study and 
were subjected to complete necropsy. The high-dose male was euthanized in extremis following 
fractures of nasal bone and hard palate with subsequent inflammations; the cause of death for the high-
dose female was not completely clear, but may have been related to a gavage accident. Neither of the 
two deaths was considered to be treatment-related. 
No differences between treated and control groups were noted in clinical or ophthalmic observations 
or urinalysis. Statistically significant lower final mean body weight (18 %) was reported in males of 
the 125 mg/kg bw per day group and correlated with slightly reduced feed consumption in this group. 
Slightly lower cumulative body weight was also noted in males of the 55 mg/kg bw per day group (up 
to 3.6 %) throughout the study and in females of the 125 mg/kg bw per day groups (5 %) toward the 
end of the study. 
In haematology, lower mean red blood cell counts (-5% to -23%), hemoglobin (-3% to -16%), and 
hematocrit (-2% to -12%) and higher mean values for relative (40% to 243%) and absolute 
reticulocyte counts (31% to 155%) at ≥ 55 mg/kg per day were observed in both sexes. Lower mean 
values for mean corpuscular hemoglobin concentration (MCHC) and higher mean values for mean 
corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), red cell distribution width 
(RDW), hemoglobin distribution width (HDW; females only) were present in males and females at 
125 mg/kg per day. This pattern of changes is consistent with regenerative anemia and correlates with 
hypercellularity of the bone marrow. Higher mean platelet counts (23%) were also noted in males at 
125 mg/kg per day. The observations in haematology at the top dose correlate with increased spleen 
weight at the same dose and macroscopic and microscopic findings in the spleen (brown pigmentation) 
indicative of anaemia and compensatory extramedullary haematopoiesis in both sexes and with 
hypercellularity in the bone marrow, starting at 55 mg/kg bw per day and up in males and at 125 
mg/kg bw per day in females. Macroscopic findings in the spleen were characterized as dark red 
discoloration at 55 mg/kg bw per day (1/10 female) and 125 mg/kg bw per day (4/10 males). 
Clinical chemistry analysis revealed higher serum bilirubin, phosphorus levels that were statistically 
significant at the top dose for both sexes with a trend from 5 mg/kg bw per day in males and 55 mg/kg 
bw per day in females. Additional increases that were not statistically significant were noted for 
glucose concentrations and higher enzyme activities for alkaline phosphatase (ALP), and/or sorbitol 
dehydrogenase in males and/or females. Lower triglyceride concentration was noted in the 125 mg/kg 
bw per day group males and females. The changes in bilirubin, phosphorus and ALP are consistent 
with spleen and liver pigmentation and indicate extravascular haemolysis. 
Lower thymus weight and atrophy in males at the top dose was attributed to lower body weight in that 
group. In addition to spleen and bone marrow findings, other microscopic findings included thymus 
atrophy in males, brown pigmentation of the liver Kupffer cells in both sexes and paraganglion 
hyperplasia in the periaortic soft tissue (one female) at 125 mg/kg bw per day; degeneration of the 
olfactory epithelium in the nasal levels II, III, and IV for both sexes at 55 mg/kg bw per day and 
above; and hyaline droplets in the proximal tubules of the kidneys in males, but not females, starting at 
5 mg/kg bw per day and granular casts noted at 55 mg/kg bw per day and above. Higher kidney 
weights were noted in males only, starting at the 55 mg/kg bw per day and they correlated with the 
presence of hyaline droplets and/or granular casts and is typical of hyaline droplet nephropathy 
characteristic of male rats. Minimal chronic progressive nephropathy was observed in high incidence 
(7/10 animals) in the control group and in the low-dose group (8/10). Both incidence and severity 
increased in the mid- and high-dose groups (up to 100 % affected, but severity not more than 20 % 
‘mild’ in the high-dose group). According to the study report, these renal changes in the males are not 
observed in the female animals and not relevant for other species, including humans (see also Hard et 
al., 1993; Hard and Khan, 2004; Hard, 2008).  
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It was concluded that oral exposure to 2-methyltetrahydrofuran-3-thiol resulted in no adverse effects 
in the 5 mg/kg bw per day group of females. In males, findings in the kidneys were noted at this dose. 
However, such observations are commonly seen in male rats and the Panel did not consider these to be 
relevant to humans (Hard and Kahn, 2004; Hard, 2008). Treatment-related effects in males and 
females noted at 55 mg/kg bw per day and above consisted of decreased body weight, olfactory 
epithelium degeneration and changes in haematological parameters and findings in the spleen, liver 
and bone marrow consistent with increased extramedullary haematopoiesis with associated 
extravascular haemolysis. Therefore, the NOAEL of 2-methyltetrahydrofuran-3-thiol was 5 mg/kg bw 
per day for male and female Crl:CD (SD) rats, exposed to 2-methyltetrahydrofuran-3-thiol for 90 days. 
A summary of the results of the 14-day and 90-day studies are shown in Table 3. 
6. Application of the procedure 
6.1. Application of the procedure to 33 sulfur-substituted furan derivatives by the JECFA12 
(JECFA, 2003) 
According to the JECFA 18 of the substances belong to structural class II and 15 to structural class III 
using the decision tree approach presented by Cramer et al. (Cramer et al., 1978). 
‘None of the flavouring agents in this group was predicted to be metabolised to innocuous products. 
The evaluation of these agents therefore proceeded down the B (right-hand) side of the decision tree.  
Step B3: The current estimated daily per capita intakes of each of the 33 flavouring agents in this 
group is below the threshold for human intake for the respective structural classes (540 mg per day for 
structural class II and 90 mg per day for structural class III). Accordingly, the evaluation of all 33 
substances in the group proceeded to step B4. 
Step B4: The NOEL for 2-methyl-3-furanthiol (FL-no: 13.055, JECFA no: 1060) in a 90-day dietary 
study in rats was 5 mg/kg bw per day (Oser, 1970b). This NOEL is appropriate for ethanoic acid, S-(2-
methyl-3-furanyl) ester (FL-no: 13.153, JECFA no: 1069) because the acetate ester would be 
hydrolysed to 2-methyl-3-furanthiol (FL-no: 13.055, JECFA no: 1060). This NOEL is also appropriate 
for the closely structurally related agent, 2,5-dimethyl-3-furanthiol (FL-no: 13.071, JECFA no: 1063). 
The NOEL for furfuryl isopropyl sulfide (FL-no: 13.032, JECFA no: 1077) in a 90-day dietary study 
in rats was 1.3 mg/kg bw per day (Posternak et al., 1969). This NOEL is also appropriate for three 
structurally related sulfides, 2-methyl-3-(methylthio)furan (FL-no: 13.152, JECFA no: 1061), 2- 
methyl-5-(methylthio)furan (FL-no: 13.065, JECFA no: 1062) and furfuryl methyl sulfide (FL-no: 
13.053, JECFA no: 1076), which would be expected to participate in the same metabolic pathways as 
furfuryl isopropyl sulfide.  
The NOEL for methyl 2-methyl-3-furyl disulfide (FL-no: 13.079, JECFA no: 1064) in a 90-day 
dietary study in rats was 1.2 mg/kg bw per day (Gallo et al., 1976a). This NOEL is also appropriate for 
three structurally related disulfides, propyl 2-methyl-3-furyl disulfide (FL-no: 13.082, JECFA no: 
1065), methyl furfuryl disulfide (FL-no: 13.064, JECFA no: 1078) and furfuryl propyl disulfide (FL-
no: 13.197, JECFA no: 1079).  
The NOEL for bis(2-methyl-3-furyl) disulfide (FL-no: 13.016, JECFA no: 1066) in a 90-day dietary 
study in rats was 0.45 mg/kg bw per day (Morgareidge and Oser, 1970a). This NOEL is also 
appropriate for a structurally related bis-disulfide, bis(2,5-dimethyl-3-furyl) disulfide (FL-no: 13.015, 
JECFA no: 1067). 
                                                     
12  The text is taken verbatim from the indicated reference source, but text related to substances not included in the present 
FGE has been removed 
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The NOEL for furfuryl mercaptan (FL-no: 13.026, JECFA no: 1072) in a multiple-dose, 13-week 
study in rats treated by gavage was 3 mg/kg bw per day (Phillips et al., 1977); and the NOEL for 
furfuryl thioacetate (FL-no: 13.033, JECFA no: 1074) in a 90-day dietary study in rats was 0.83 mg/kg 
bw per day (Posternak et al., 1969). These NOELs are also appropriate for the esters furfuryl 
thioformate (FL-no: 13.051, JECFA no: 1073) and furfuryl thiopropionate (FL-no: 13.063, JECFA no: 
1075), because they are either close structural relatives of furfuryl thioacetate (FL-no: 13.033, JECFA 
no: 1074) or are expected to be hydrolysed to furfuryl mercaptan (FL-no: 13.026, JECFA no: 1072). 
The NOEL of 3 mg/kg bw per day for furfuryl mercaptan (FL-no: 13.026, JECFA no: 1072) is also 
appropriate for 2,2'-(dithiodimethylene) difuran (FL-no: 13.050, JECFA no: 1081), because this 
chemical is anticipated to be readily reduced to furfuryl mercaptan.  
The NOEL for 2,5-dimethyl-3-thiofuroyl furan (FL-no: 13.040, JECFA no: 1071) in a 90-day dietary 
study in rats was 0.74 mg/kg bw per day (Morgareidge et al., 1974b). This NOEL is appropriate for 
methyl thiofuroate (FL-no: 13.142, JECFA no: 1083), because both 2,5-dimethyl-3-thiofuroyl furan 
and methyl thiofuroate would be hydrolysed to furoic acid.  
The NOEL for 3-[(2-methyl-3-furyl)thio]-4-heptanone (FL-no: 13.077, JECFA no: 1085) in a 90- day 
dietary study in rats was 3.8 mg/kg bw per day (Gallo et al., 1976b). This NOEL is also appropriate 
for three structurally related thioketones, 4-[(2-methyl-3-furyl)thio]-2-pentanone (FL-no: 13.196, 
JECFA no: 1084), 2,6-dimethyl-3-[(2-methyl-3-furyl)thio]-4-heptanone (FL-no: 13.075, JECFA no: 
1086) and 4-[(2-methyl-3-furyl)thio]-5-nonanone (FL-no: 13.078, JECFA no: 1087).  
The NOEL for 2,2'-(thiodimethylene) difuran (FL-no: 13.056, JECFA no: 1080) in a 14-day study in 
rats treated in the diet was 10 mg/kg bw per day (Gill and Van Miller, 1987); that for bis(2-methyl-3-
furyl) tetrasulfide (FL-no: 13.017, JECFA no: 1068) in a 90-day study was 0.56 mg/kg bw per day 
(Morgareidge and Oser, 1970b); that for 2,5-dimethyl-3-furan thioisovalerate (FL-no: 13.041, JECFA 
no: 1070) in a 90-day study was 0.73 mg/kg bw per day (Morgareidge et al., 1974a); that for 2-methyl-
3-, 5- or 6-(furfurylthio)pyrazine (FL-no: 13.151, JECFA no: 1082) in a 90-day study was 1.7 mg/kg 
bw per day (Posternak et al., 1975); and that for ethyl 3-(furfurylthio)propionate (FL-no: 13.093, 
JECFA no: 1088) in a 90-day study was 17 mg/kg bw per day (Bio-Research Laboratory, 1980).  
The NOEL for 2-methylthioacetoxy-4,5-dihydrofuran (FL-no: 13.086, JECFA no: 1089) in a 1-year 
dietary study in rats was 8.3 mg/kg bw per day (Munday and Gellatly, 1974). This NOEL is also 
appropriate for three structurally related analogues, 2-methyl-3-tetrahydrofuranthiol (FL-no: 13.160, 
JECFA no: 1090), cis- and trans-2,5-dimethyl-3-tetrahydrofuranthiol (FL-no: 13.193, JECFA no: 
1091) and cis-and trans-2,5-dimethyltetrahydro-3-furyl thioacetate (FL-no: 13.194, JECFA no: 1092), 
because these chemicals are expected to be hydrolysed to the corresponding dihydro- or 
tetrahydrofuranthiol.  
The stepwise evaluations of the 33 substances evaluated by the JECFA are summarised in Table 4. 
6.2. Application of the procedure to 27 furfuryl and furan derivatives with and without 
additional side-chain substituents and heteroatoms by EFSA
13
 in FGE.13Rev2 (EFSA 
CEF Panel, 2011) 
Only the text relevant for FGE.65Rev1 has been included here. Where necessary some editorial 
changes were included to maintain legibility and numbers of substances evaluated in FGE.13Rev2 
refer only to the number of sulfur-containing furan derivatives (i.e. 14 from main group II out of the 
25 substances considered in FGE.13Rev2). 
For the safety evaluation of the sulfur-containing candidate substances the Procedure as outlined in 
Appendix A was applied. The stepwise evaluations of the 14 substances of main group II of 
FGE13Rev2 are summarised in Table 5. 
                                                     
13 The text is taken verbatim from the indicated reference source, but text related to substances not included in the present 
FGE has been removed 
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Step 1  
One of these 14 sulfur-containing candidate substances evaluated via the Procedure are classified into 
structural class II and 13 are classified into structural class III according to the decision tree approach 
by Cramer et al. (Cramer et al., 1978) (see Table 2a of FGE.13Rev2). 
Step 2 
Taking into account the metabolic pathways described in Section 4, none of the candidate substances 
are predicted to be metabolised to innocuous products. Therefore, the evaluation of the 14 sulfur-
containing candidate substances proceeds via the B-side of the evaluation scheme. 
Step B3 
The one candidate substance [FL-no: 13.145], which has been assigned to structural class II, has an 
estimated European daily per capita intakes (MSDI) of 0.0024 µg (Table 2a of FGE.13Rev2). This 
intake is below the threshold of concern of 540 µg/person per day for structural class II. The estimated 
daily per capita intakes of the 13 candidate substances assigned to structural class III range from 
0.0012 to 37 µg, which is also below the threshold of concern for the structural class of 90 µg/person 
per day. Therefore, the safety evaluation proceeds to step B4 for all 14 candidate substances. 
Step B4 
Since no toxicity data are available on the sulfur-containing candidate substances in main group II of 
FGE.13Rev1, the relevant NOAEL values originate from structurally related supporting substances. 
Subgroup IIa sulphides [FL-no: 13.114, 13.124, 13.141, 13.143, 13.145 and 13.199]: 
The candidate substances ethyl furfuryl sulfide [FL-no: 13.124], methyl 5-methylfurfuryl sulfide [FL-
no: 13.145] and 2,5-dimethyl-3-(methylthio)furan [FL-no: 13.114] are expected to participate in the 
same metabolic pathways as the supporting substance furfuryl isopropyl sulfide [FL-no: 13.032] and 
therefore to have same toxicological properties. No effects were observed for furfuryl isopropyl 
sulfide in a 90-day dietary study with rats at a single dose level (1.34 mg/kg bw per day) (Posternak et 
al., 1969). Comparison of the only level tested with no effect taken as a NOAEL with the estimated 
daily per capita intakes based on the MSDI approach and expressed in µg/kg bw per day for ethyl 
furfuryl sulfide [FL-no: 13.124], methyl 5-methylfurfuryl sulfide [FL-no: 13.145] and 2,5-dimethyl-3-
(methylthio)furan [FL-no: 13.114] provides adequate margins of safety > 10
5
. 
After ester hydrolysis, the candidate substances methyl (2-furfurylthio)acetate and methyl 3-
furfurylthio) propionate [FL-no: 13.141 and 13.143] are anticipated to be metabolised and to have 
toxicological properties similar to the supporting substance ethyl-3-(2-furfurylthio) propionate [FL-no: 
13.093]. For this substance an NOAEL of 5.78 mg/kg bw per day has been identified in a 90-day study 
(Bio-Research Laboratory, 1980). Comparison of this NOAEL with the estimated daily per capita 
intakes based on the MSDI approach and expressed in µg/kg bw per day of methyl (2-
furfurylthio)acetate and methyl 3-furfurylthio) propionate [FL-no: 13.141 and 13.143] provides an 
adequate margin of safety of 3.2  107 for both substances. 
Candidate substance 3-[(2-methyl-3-furyl)thio]-butanal [FL-no: 13.199] may be evaluated by 
comparison of its exposure with the NOAEL from supporting substance 3-[(2-methyl-3-furyl)thio]-4-
heptanone [FL-no: 13.077]. 3-[(2-Methyl-3-furyl)thio]-4-heptanone was tested in rats at a single dose 
level of 3.76 mg/kg bw per day in the diet for 90 days without treatment-related effects (Gallo et al., 
1976b). Comparison of the estimated daily per capita intakes based on the MSDI approach for 3-[(2-
methyl-3-furyl)thio]-butanal [FL-no: 13.199] with the NOAEL of 3.76 mg/kg bw per day for the 
supporting substance provided an adequate margin of safety of 1.9 × 10
5
. 
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Subgroup IIb thiols [FL-no: 13.108 and 13.149]: 
The candidate substance 5-methyl-2-furanmethanethiol [FL-no: 13.149] is structurally related to the 
supporting substance 2-furanmethanethiol [FL-no: 13.026]. The NOAEL of 2-furanmethanethiol in a 
multiple dose level 91-day oral gavage study with rats was 3 mg/kg bw per day (Phillips et al., 1977). 
Comparison of the NOAEL for 2-furanmethanethiol with the estimated daily per capita intake based 
on the MSDI approach expressed in µg/kg bw per day of 5-methyl-2-furanmethanethiol [FL-no: 
13.149] provides an adequate margin of safety of 4.9  105. 
The candidate substance 4,5-dihydro-3-mercapto-2-methylfuran [FL-no: 13.108] is structurally related 
to the supporting substance 2-methyl-3-thioacetoxy-4,5-dihydrofuran [FL-no: 13.086] from subgroup 
IIe. Several subchronic studies have been carried out with this supporting substance. A NOAEL of 1.4 
mg/kg bw per day has been derived in a multiple dose level 13 weeks dietary study with rats (Munday 
and Gellatly, 1973). Comparison of the NOAEL for 2-methyl-3-thioacetoxy-4,5-dihydrofuran with the 
estimated daily per capita intake based on the MSDI approach expressed in µg/kg bw per day of 4,5-
dihydro-3-mercapto-2-methylfuran [FL-no: 13.108] provided an adequate margin of safety of 
2.3  103. 
Subgroup IIc disulphides [FL-no: 13.113, 13.144, 13.178 and 13.185]: 
In the previous version of this FGE, the candidate substance 2,5-dimethyl-3-(methyldithio)furan [FL-
no: 13.113] was evaluated against a NOAEL which turned out to belong to a structurally unrelated 
substance. Therefore this evaluation was not valid and thus substance [FL-no: 13.113] had to be 
reconsidered. It may be anticipated that this disulphide will be subject to fission of the disulphide 
bridge. The resulting furan-containing fragment, which is more reactive than the disulphide itself, 
could be evaluated by comparison with the toxicity of 2-methyl-3-furanthiol [FL-no: 13.055] from 
subgroup IIb. The NOAEL of 2-methyl-3-furanthiol in a multiple dose level 90-day oral gavage study 
with rats was 5 mg/kg bw per day (Oser, 1970b). When the NOAEL for 2-methyl-3-furanthiol is 
compared with the estimated daily per capita intake based on the MSDI approach expressed in µg/kg 
bw per day for 2,5-dimethyl-3-(methyldithio)furan [FL-no: 13.113] an adequate margin of safety of 25 
× 10
7
 can be calculated. 
For the candidate substances methyl 5-methylfurfuryl disulfide [FL-no: 13.144] and 2-furfuryl 3-oxo-
2-butyl disulphide [FL-no: 13.185] a NOAEL for a comparable substance is not available. However, 
after fission of the disulphide bridge the resulting furan-containing fragment, which is more reactive 
than the disulphide itself, could be evaluated by comparison with the toxicity of furfuryl mercaptan 
[FL-no: 13.026] from subgroup IIb. The NOAEL of furfuryl mercaptan in a multiple dose level 91-day 
oral gavage study with rats was 3 mg/kg bw per day (Phillips et al., 1977). When the NOAEL for 
furfuryl mercaptan is compared with the estimated daily per capita intakes based on the MSDI 
approach expressed in µg/kg bw per day for methyl 5-methylfurfuryl disulfide [FL-no: 13.144] and 2-
furfuryl 3-oxo-2-butyl disulphide [FL-no: 13.185], adequate margins of safety of 75 × 10
6
 and 
16  106, respectively, can be calculated. 
The Panel noted that the candidate substance 3-(furfuryldithio)-2-methylfuran [FL-no: 13.178] is 
synonymous with [FL-no: 13.192]. The latter substance has been assigned the JECFA number 1524 in 
the report of the 69th meeting (JECFA, 2009). For this substance, in the JECFA evaluation, an MSDI 
for Europe of 0.24 µg per capita per day was given. This figure, which is higher and more recent than 
the exposure estimate in the previous version of this FGE (0.0012 µg per capita per day), will be used 
in the current revision of this FGE. The candidate substance 3-(furfuryldithio)-2-methylfuran [FL-no: 
13.178] is structurally related to the supporting substance bis(2-methyl-3-furyl) disulfide [FL-no: 
13.016], which has been tested in two single-dose-level 90-day dietary studies with rats at 5 mg/kg bw 
per day and 0.45 mg/kg bw per day, respectively (Oser, 1970a; Morgareidge and Oser, 1970a). 
Treatment-related effects were seen at the intake level of 5.0 mg/kg bw per day, but the intake level of 
0.45 mg/kg bw per day was determined to be a NOAEL. The disulphide bridge fission products are 
related to [FL-no: 13.026] for which a NOAEL of 3 mg/kg bw per day has been derived. When the 
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estimated daily per capita intake based on the MSDI approach expressed in µg/kg bw per day of 3-
(furfuryldithio)-2-methylfuran [FL-no: 13.178] is compared to this NOAEL an adequate margins of 
safety of 1.1 × 10
5
 can be calculated.  
Alternatively, the two fission products of 3-(furfuryldithio)-2-methylfuran [FL-no: 13.178] may be 
considered separately. These fission products are [FL-no: 13.055] and [FL-no: 13.026], for which 
NOAELs of 5 mg/kg bw per day and 3 mg/kg bw per day, respectively, have been derived (Oser, 
1970b; Phillips et al., 1977). Exposure to [FL-no: 13.178] at the level of its MSDI would correspond 
to exposures to [FL-no: 13.026] and [FL-no: 13.055] of 0.12 µg per person per day for both fragments. 
Comparison of these exposure estimates to the NOAELs for these two fragments provides adequate 
margins of safety of 1.5  106 and 2.5  106 for [FL-no: 13.026] and [FL-no: 13.055], respectively. 
Subgroup IId polysulphide [FL-no: 13.146]: 
The one candidate flavouring substance in this subgroup methyl furfuryl trisulphide [FL-no: 13.146] is 
a trisulphide which may be anticipated to release perthiols upon metabolism. Similar reactive products 
may be anticipated for bis-(2-methyl-3-furyl)tetrasulphide [FL-no: 13.017] for which a NOAEL of 
0.56 mg/kg bw per day in a 90-day study has been derived (Morgareidge and Oser, 1970b). 
Comparison of this NOAEL with the estimated daily per capita intake of methyl furfurul trisulphide 
[FL-no: 13.146] based on the MSDI approach expressed in µg/kg bw per day of 0.0024 µg provides an 
adequate margin of safety of 14 × 10
6
. 
Subgroup IIe thioester [FL-no: 13.135]: 
The thiol released after hydrolysis of the candidate substance 1-(2-furfurylthio)propanone [FL-no: 
13.135] is the supporting substance 2-furanmethanethiol [FL-no: 13.026] from subgroup IIb. The 
NOAEL of 2-furanmethanethiol in a multiple dose level 91-day oral gavage study with rats was 3 
mg/kg bw per day (Phillips et al., 1977). Comparison of the NOAEL for 2-furanmethanethiol with the 
estimated daily per capita intake based on the MSDI approach expressed in µg/kg bw per day of 1-(2-
furfurylthio)propanone provides an adequate margin of safety of 1.6  107.  
Summary: 
For the six, two, four, one and one substances in subgroups IIa, IIb, IIc, IId and IIe, respectively, 
which have been evaluated through the Procedure, it can be concluded at step B4 of the Procedure that 
these 14 candidate substances do not pose a safety concern when used as flavouring substances at the 
estimated levels of intake based on the MSDI approach.  
6.3. EFSA considerations  
The Panel agrees with the way the application of the Procedure has been performed by the JECFA for 
the candidate substances included in this FGE.  
At step 1 the classification according to Cramer et al, 1977 was revised from class II to III for 11 of 
the flavouring substances [FL no: 13.033, 13.056, 13.065, 13.071, 13.079, 13.082, 13.142, 13.153, 
13.160, 13.196 and 13.197]. These revisions were consistent with the classifications in the related 
FGE.13Rev2 and FGE.67Rev1, and do not change the routing of these substances through the 
Procedure. The Panel noted that differences between the conclusions reached for individual substances 
by the Panel and those reached by the JECFA do not result from the revisions of the classifications 
according to the Cramer system. 
For 23 substances [FL-no: 13.016, 13.017, 13.026, 13.033, 13.040, 13.041, 13.050, 13.051, 13.053, 
13.055, 13.065, 13.071, 13.075, 13.077, 13.078, 13.086, 13.152, 13.153, 13.015, 13.032, 13.063, 
13.093 and 13.151] NOAELs could be identified at step B4 of the Procedure, either for the substances 
themselves, or for closely related substances. At step B4 it was concluded that these 23 substances 
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would not represent a safety concern at their estimated levels of intake as flavouring substance based 
on the MSDI approach. 
For 10 substances the Panel did not agree with the JECFA with respect to the NOAEL used at step B4 
of the Procedure: 
S-methyl 2- furanthiocarboxylate [FL-no: 13.142] 
For substance [FL-no: 13.142] the Panel considered that upon hydrolysis this substance would yield 
furoic acid and methylmercaptan in amounts of 0.29 and 0.13 µg per person per day, respectively, 
when the intake of [FL-no: 13.142] would equal the MSDI. In FGE.13Rev1 furoic acid has been 
evaluated by comparison with the ADI for furfural. This ADI is 0.5 mg/kg bw per day, equivalent to 
30 mg per person per day. Thus, it is not anticipated that the exposure to furoic acid resulting from the 
hydrolysis of [FL-no: 13.142] would represent a safety concern. No NOAEL is available for the 
methylmercaptan fragment, but for the evaluation of this fragment the NOAEL of 6.7 mg/kg bw per 
day for [FL-no: 12.018; S-Ethyl acetothioate] found in a 90-day study by Shellenberger 
(Shellenberger, 1970) may be used. This NOAEL would represent a dose of 4 mg/kg bw per day of 
ethylmercaptan. When this value is compared to the exposure estimate of methylmercaptan resulting 
from intake of [FL-no: 13.142] at the estimated level of intake, an adequate margin of safety of 1.9  
10
6
 can be calculated. 
The NOAEL for substance methyl 2-methyl-3-furyl disulfide [FL-no: 13.079] appeared to be invalid 
because the JECFA took this NOAEL from a study carried out with a structurally unrelated substance. 
Therefore the evaluation of this substance and the evaluation of three other substances [FL-no: 13.064, 
13.082 and 13.197], which depended on this NOAEL, should be reconsidered. 
Methyl 2-methyl-3-furyl disulfide [FL-no: 13.079] 
For the candidate substance methyl 2-methyl-3-furyl disulfide [FL-no: 13.079] a NOAEL for a 
comparable substance is not available. However, after fission of the disulphide bridge the resulting 
furan-containing fragment is 2-methyl-3-furanthiol [FL-no: 13.055], which is more reactive than the 
disulphide itself. The NOAEL of 2-methyl-3-furanthiol in a multiple dose level 90-day oral gavage 
study with rats was 5 mg/kg bw per day (Oser, 1970b). When exposed to [FL-no: 13.079] at the level 
of the MSDI a maximum daily exposure to 2-methyl-3-furanthiol [FL-no: 13.055] of 0.52 g per 
person per day can be calculated. When this exposure is compared with the NOAEL for 2-methyl-3-
furanthiol an adequate margin of safety of 5.8 × 10
5
 can be calculated. For the methylmercaptan 
fragment a margin of safety of 1.1  106 can be calculated in the same way as described above for [FL-
no: 13.142]. 
Propyl 2-methyl-3-furyl disulfide [FL-no: 13.082] 
For the candidate substance propyl 2-methyl-3-furyl disulfide [FL-no: 13.082] a NOAEL for a 
comparable substance is not available. However, after fission of the disulphide bridge the resulting 
furan-containing fragment is 2-methyl-3-furanthiol [FL-no: 13.055], which is more reactive than the 
disulphide itself. The NOAEL of 2-methyl-3-furanthiol in a multiple dose level 90-day oral gavage 
study with rats was 5 mg/kg bw per day (Oser, 1970b). When exposed to [FL-no: 13.082] at the level 
of the MSDI a maximum daily exposure to 2-methyl-3-furanthiol [FL-no: 13.055] of 0.07 g per 
person per day can be calculated. When this exposure is compared with the NOAEL for 2-methyl-3-
furanthiol an adequate margin of safety of 4.1 × 10
6
 can be calculated. For the propylmercaptan 
fragment a margin of safety of 4.9  106 can be calculated in the same way as described above for the 
methylmercaptan fragment of [FL-no: 13.142]. 
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Methyl-furfuryl disulfide [FL-no: 13.064] 
For the candidate substance methyl furfuryl disulfide [FL-no: 13.064] a NOAEL for a comparable 
substance is not available. However, after fission of the disulphide bridge the resulting furan-
containing fragment is 2-furanmethanethiol [FL-no: 13.026], which is more reactive than the 
disulphide itself. The NOAEL of 2-furanmethanethiol in a multiple dose level 91-day oral gavage 
study with rats was 3 mg/kg bw per day (Phillips et al., 1977). When exposed to [FL-no: 13.064] at the 
level of the MSDI a maximum daily exposure to 2-furanmethanethiol of 0.61 g per person per day 
can be calculated. When this exposure is compared with the NOAEL for 2-furanmethanethiol an 
adequate margin of safety of 3 × 10
5
 can be calculated. For the methylmercaptan fragment a margin of 
safety of 9.4  105 can be calculated in the same way as described above for the methylmercaptan 
fragment from [FL-no: 13.142]. 
Furfuryl propyl disulfide [FL-no: 13.197] 
For the candidate substance furfuryl propyl disulfide [FL-no: 13.197] a NOAEL for a comparable 
substance is not available. However, after fission of the disulphide bridge the resulting furan-
containing fragment is 2-furanmethanethiol [FL-no: 13.026], which is more reactive than the 
disulphide itself. The NOAEL of 2-furanmethanethiol in a multiple dose level 91-day oral gavage 
study with rats was 3 mg/kg bw per day (Phillips et al., 1977). When exposed to [FL-no: 13.197] at the 
level of the MSDI a maximum daily exposure to 2-furanmethanethiol of 0.15 g per person per day 
can be calculated. When this exposure is compared with the NOAEL for 2-methyl-3-furanthiol an 
adequate margin of safety of 12 × 10
6
 can be calculated. For the propylmercaptan fragment a margin 
of safety of 24  106 can be calculated in the same way as described above for the methylmercaptan 
fragment from [FL-no: 13.142]. 
4-(Furfuryl-thio)-pentan-2-one [FL-no: 13.196] 
The Panel noted that the name and structure of the JECFA substance 1084 as presented in JECFA 
(JECFA, 2003) were inconsistent with the CAS number provided for this substance. After 
correspondence with Industry, the correct name and structure were provided (see Table 1). As the 
substance with the corrected name and structure deviates substantially from the substance evaluated by 
the JECFA, this substance has to be reconsided at step B4 of the Procedure. A NOAEL for substance 
[FL-no: 13.196] was not identifed. The Panel considered this substance to be structurally related to the 
supporting substance 3-[(2-methyl-3-furyl)thio]-4-heptanone [FL-no: 13.077]. For this substance a 
NOAEL of 3.76 mg/kg bw per day could be derived from a 90 day dietary single dose level study in 
rats (Gallo et al., 1976b). When the exposure estimate for 4-(furfurylthio)-pentan-2-one [FL-no: 
13.196] at the level of the MSDI (0.012 µg per capita per day) is compared to this NOAEL an 
adequate margin of safety of 18.8  106 can be calculated. 
[FL-no: 13.160, 13.193 and 13.194] 
For three substances [FL-no: 13.160, 13.193 and 13.194] the Panel disagreed with the JECFA with 
respect to the proposed use of the NOAEL for [FL-no: 13.086] because the Panel considered the 
tetrahydrofuran ring in [FL-no: 13.160, 13.193 and 13.194] not sufficiently similar to the dihydrofuran 
ring in [FL-no: 13.086]. Therefore a NOAEL supporting these three substances was not available, and 
the Panel requested a new 90-day repeated dose toxicity study with the representative substance, 2,5-
dimethyltetrahydro-3-furylthiol acetate [FL-no: 13.194]. In response to this request expressed in 
FGE.65, the Flavour Industry has now submitted a range-finding 14-day study and a 90-day study in 
rats (the 90-day toxicity study is summarised in Section 6) with substance [FL-no: 13.160]. The Panel 
accepted the arguments provided by EFFA (see the section ‘Background as provided by the European 
Commission’) to support the submission of testing results with a different representative substance.  
Based on this new study the Panel could derive a NOAEL of 5 mg/kg bw per day. When the exposure 
estimates, based on MSDI for the three substances [FL-no: 13.160, 13.193 and 13.194] of 55, 0.012, or 
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0.012µg per capita per day are compared to the NOAEL of 5 mg/kg bw per day for [FL-no: 13.160], 
adequate margins of safety of 5400, 2.5 × 10
7
 or 2.5 × 10
7
 or can be calculated, respectively. 
Difurfuryl sulfide [FL-no: 13.056] 
For difurfuryl sulfide [FL-no: 13.056] the Panel decided that the available NOAEL from a 14-day 
study was inappropriate to draw a conclusion on its safety when used as a flavouring substance. 
CONCLUSION 
The present evaluation deals with 33 substances in the JECFA flavouring group of sulfur-substituted 
furan derivatives. These substances are structurally related to the group of sulfur-substituted furans 
evaluated within the group of ‘Furfuryl and furan derivatives with and without additional side-chain 
substituents and heteroatoms from chemical group 14’ evaluated by EFSA in FGE.13Rev2.  
The present revision of FGE.65, FGE.65Rev1 is due to the availability of new toxicity data on 2-
methyltetrahydrofuran-3-thiol [FL-no: 13.160], requested by the Panel in FGE.65. 
The Panel agrees with the way the application of the Procedure has been performed by the JECFA for 
the candidate substances included in this FGE. For 23 substances the Panel also agreed with JECFA 
with respect to the choice of the NOAEL to finalise the evaluation. For nine substances the NOAEL 
used by JECFA was considered invalid, but the Panel could finalise the evaluations of these 
substances using NOAELs derived from new or existing data either for the candidate substances or 
forsupporting substances. Thus, for 32 substances the Panel reached the same conclusion as JECFA 
with respect to their use as chemically defined flavouring substances in food. For one substance [FL-
no: 13.056] no adequate NOAEL could be identified by the Panel and subsequently, no conclusion as 
to the safety when used at levels of intake estimated using the MSDI approach could be reached. 
For all 33 substances evaluated through the Procedure by JECFA use levels are needed to calculate the 
mTAMDIs in order to identify those flavouring substances that need more refined exposure 
assessment and to finalise the evaluation. 
In order to determine whether the conclusion for the 33 JECFA evaluated substances can be applied to 
the materials of commerce, it is necessary to consider the available specifications: Adequate 
specifications including complete purity criteria and identity are available for all of the JECFA 
evaluated substances. 
Thus, the Panel has reservations for one substance [FL-no: 13.056] for which additional toxicity data 
are needed. The Panel is aware, that data for [FL-no: 13.056] were not submitted before the deadline 
as indicated in Commission Implementing Regulation (EC) No 872/2012. The Commission has 
communicated that this substance is in the process of being deleted from the Union List. For the 
remaining 32 JECFA evaluated sulfur-substituted furan derivatives [Fl-nos: 13.015, 13.016, 13.017, 
13.026, 13.032, 13.033, 13.040, 13.041, 13.050, 13.051, 13.053, 13.055, 13.056, 13.063, 13.064, 
13.071, 13.075, 13.077, 13.078, 13.079, 13.082, 13.086, 13.093, 13.142, 13.151, 13.152, 13.153, 
13.160, 13.193, 13.194, 13.196 and 13.197], the Panel agrees with JECFA conclusion ‘No safety 
concern at estimated levels of intake as flavouring substances’ based on the MSDI approach. 
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SUMMARY OF TOXICITY DATA  
Table 3:  Toxicity data considered by the Panel in FGE.65Rev1 
Chemical Name  
[FL-no:] 
Species; Sex 
No/group 
Route  Doses 
(mg/kg bw per day) 
Duration 
(days) 
NOAEL 
(mg/kg bw per 
day) 
Reference  Comments 
2-Methyltetrahydrofuran-3-thiol 
[13.160] 
Rat; M, F  
3 
Diet 0, 75, 500 and 1000  14 75 (Kappeler, 2013)  
Rat; M, F  
3 
Gavage 0, 5, 55 and 125  90 5 (Kappeler, 2014)  
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SUMMARY OF SAFETY EVALUATIONS 
Table 4:  Summary of safety evaluation by the JECFA (JECFA, 2003) 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI(a)  
US MSDI 
(g/capita per 
day) 
Class(b) 
Evaluation procedure 
path(c) 
Outcome on 
the named 
compound(d),(e) 
EFSA conclusion 
on the named 
compound(f) 
EFSA conclusion on the 
material of commerce 
13.016 
1066 
bis-(2-Methyl-3-
furyl) disulfide 
O
S
S
O
 
0.27 
0.7 
Class II 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
13.026 
1072 
2-
Furanmethanethiol 
O
SH
 
29 
11 
Class II 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
13.050 
1081 
Difurfuryl disulfide 
S
SO
O
 
3.3 
0.7 
Class II 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
13.053 
1076 
Methyl furfuryl 
sulfide S
O
 
0.97 
0.1 
Class II 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
13.055 
1060 
2-Methylfuran-3-
thiol 
O
SH  
0.52 
0.9 
Class II 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI approach. 
According to JECFA: 
Min. assay value is ‘95’ 
and secondary 
components ‘Bis(2-
methyl-3-furyl)disulfide’. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
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Table 4:  Summary of safety evaluation by the JECFA (JECFA, 2003) 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI(a)  
US MSDI 
(g/capita per 
day) 
Class(b) 
Evaluation procedure 
path(c) 
Outcome on 
the named 
compound(d),(e) 
EFSA conclusion 
on the named 
compound(f) 
EFSA conclusion on the 
material of commerce 
13.064 
1078 
Methyl furfuryl 
disulfide 
S
SO
 
0.85 
0.04 
Class II 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
13.152 
1061 
2-Methyl-3-
(methylthio)furan 
O
S  
1.2 
0.1 
Class II 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
13.015 
1067 
bis-(2,5-Dimethyl-
3-furyl) disulfide 
O
S
S
O
 
0.012 
0.7 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
13.017 
1068 
bis-(2-Methyl-3-
furyl) tetrasulfide 
O
OS
S
S
S
 
0.97 
0.7 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
13.032 
1077 
Furfuryl isopropyl 
sulfide O
S
 
0.0012 
0.1 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
13.033 
1074 
S-Furfuryl 
acetothioate O
S
O
 
0.43 
0.05 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
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Table 4:  Summary of safety evaluation by the JECFA (JECFA, 2003) 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI(a)  
US MSDI 
(g/capita per 
day) 
Class(b) 
Evaluation procedure 
path(c) 
Outcome on 
the named 
compound(d),(e) 
EFSA conclusion 
on the named 
compound(f) 
EFSA conclusion on the 
material of commerce 
13.040 
1071 
(S)-2,5-Dimethyl-3-
thiofuroylfuran 
O
O
S
O
 
0.012 
0.01 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI approach. 
JECFA evaluated (S)-2,5-
dimethyl-3-
thiofuroylfuran (CASrn as 
in Register). No safety 
concern at the estimated 
level of intake based on 
the MSDI approach. 
13.041 
1070 
2,5-Dimethyl-3-
(isopentylthio)furan 
O
S
O
 
0.49 
0.7 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI approach. 
Registername to be 
changed to 2,5-dimethyl-
3-(isovalerylthio)furan. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
13.051 
1073 
S-Furfuryl 
thioformate 
O
S O
 
1.3 
0.02 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
13.056 
1080 
Difurfuryl sulfide 
S
OO
 
0.73 
0.005 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d Toxicity data are 
required. No 
adequate NOAEL 
exists. 
The Panel is aware that 
data were not submitted 
before the deadline as 
indicated in Commission 
Implementing Regulation 
(EC) No 872/2012. The 
Commission has 
communicated that this 
substance is in the process 
of being deleted from the 
Union List. 
13.063 
1075 
S-Furfuryl 
propanethioate 
O
S
O
 
0.012 
0.005 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
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Table 4:  Summary of safety evaluation by the JECFA (JECFA, 2003) 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI(a)  
US MSDI 
(g/capita per 
day) 
Class(b) 
Evaluation procedure 
path(c) 
Outcome on 
the named 
compound(d),(e) 
EFSA conclusion 
on the named 
compound(f) 
EFSA conclusion on the 
material of commerce 
13.065 
1062 
2-Methyl-5-
(methylthio)furan 
O S
 
1.1 
0.02 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
13.071 
1063 
2,5-Dimethylfuran-
3-thiol 
O
SH  
0.024 
0.7 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
13.075 
1086 
2,6-Dimethyl-3-((2-
methyl-3-
furyl)thio)heptan-4-
one 
O
S
O  
1.8 
0.7 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI approach. 
According to JECFA: 
Min. assay value is ‘94’ 
and secondary 
components ‘2,6-
Dimethyl-2-[(2-methyl-3-
furyl)thio]-4-heptanone’. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
13.077 
1085 
3-((2-Methyl-3-
furyl)thio)heptan-4-
one 
O
S
O  
2.9 
0.7 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
13.078 
1087 
4-((2-Methyl-3-
furyl)thio)nonan-5-
one 
O
S
O
 
0.73 
0.7 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
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Table 4:  Summary of safety evaluation by the JECFA (JECFA, 2003) 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI(a)  
US MSDI 
(g/capita per 
day) 
Class(b) 
Evaluation procedure 
path(c) 
Outcome on 
the named 
compound(d),(e) 
EFSA conclusion 
on the named 
compound(f) 
EFSA conclusion on the 
material of commerce 
13.079 
1064 
Methyl 2-methyl-3-
furyl disulfide 
O
S
S
 
0.73 
0.05 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI approach. 
According to JECFA: 
Min. assay value is ‘97’ 
and secondary 
components ‘up to 3% 
bis(2-methyl-3-
furyl)disulfide’. No safety 
concern at the estimated 
level of intake based on 
the MSDI approach. 
13.082 
1065 
Propyl 2-methyl-3-
furyl disulfide 
O
S
S
 
0.12 
0.7 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI approach. 
According to JECFA: 
Min. assay value is ‘97’ 
and secondary 
components ‘up to 2% 
bis(2-methyl-3-
furyl)disulfide and propyl 
disulfide’. No safety 
concern at the estimated 
level of intake based on 
the MSDI approach. 
13.086 
1089 
4,5-Dihydro-2-
methyl-3-
thioacetoxyfuran 
O
S
O
 
0.49 
0.7 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
13.093 
1088 
Ethyl 3-(2-
furfurylthio)propion
ate OS
O
O
 
0.012 
0.2 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
13.142 
1083 
S-Methyl 2-
furanthiocarboxylat
e 
O
S
O
 
0.37 
0.1 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
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Table 4:  Summary of safety evaluation by the JECFA (JECFA, 2003) 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI(a)  
US MSDI 
(g/capita per 
day) 
Class(b) 
Evaluation procedure 
path(c) 
Outcome on 
the named 
compound(d),(e) 
EFSA conclusion 
on the named 
compound(f) 
EFSA conclusion on the 
material of commerce 
13.151 
1082 
2-Methyl-3,5 and 6-
(furfurylthio)pyrazi
ne 
2 or 5 or 6 -Methyl-3-(furfurylthio)pyrazine
N
N
O
S
 
0.37 
0.7 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI approach. 
According to JECFA: 
Min. assay value is ‘99’ 
and ‘Mixture of isomers: 
70 % 2,3-; 29 % 2,6-; 
trace 2,5-’. No safety 
concern at the estimated 
level of intake based on 
the MSDI approach. 
13.153 
1069 
2-Methyl-3-furyl 
thioacetate 
O
S
O
 
0.012 
0.07 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI approach. 
According to JECFA: 
Min. assay value is ‘92’ 
and secondary 
components ‘cis- and 
trans-2-Methyl-3-
tetrahydrofuranthiol 
acetate’. 
 
13.160 
1090 
2-
Methyltetrahydrofur
an-3-thiol 
O
SH  
55 
0.7 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI. 
According to JECFA: 
Min. assay value is ‘97’ 
and ‘71 % trans and 26 % 
cis isomer’. 
13.193 
1091 
2,5-
Dimethyltetrahydro-
3-furanthiol 
O
SH  
0.012 
0.9 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI. 
According to JECFA: 
Min. assay value is ‘96 
(mixture of 4 
stereoisomers)’.  
Composition of 
stereoisomeric mixture to 
be specified. 
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Table 4:  Summary of safety evaluation by the JECFA (JECFA, 2003) 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI(a)  
US MSDI 
(g/capita per 
day) 
Class(b) 
Evaluation procedure 
path(c) 
Outcome on 
the named 
compound(d),(e) 
EFSA conclusion 
on the named 
compound(f) 
EFSA conclusion on the 
material of commerce 
13.194 
1092 
2,5-
Dimethyltetrahydro-
3-furyl thio acetate 
O
S
O
 
0.012 
2 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI. 
According to JECFA: 
Min. assay value is ‘90 
(mixture of 4 
stereoisomers)’ and 
secondary components 
‘2,5-
Dimethyltetrahydrofuran-
3-thiol, 
Dimethyltetrahydro-3-
furyl dithioacetate’.  
Composition of 
stereoisomeric mixture to 
be specified. 
13.196 
1084 
4-[(2-
Furanylmethyl)thio]
-2-pentanone 
O
S
O
 
0.012 
0.6 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
13.197 
1079 
Furyl propyl 
disulfide 
O
S
S
 
0.024 
3 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d No safety concern 
at the estimated 
level of intake 
based on the 
MSDI approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
(a): EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita per day. 
(b): Thresholds of concern: Class I = 1800 µg/person per day, Class II = 540 µg/person per day, Class III = 90 µg/person per day. 
(c): Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
(d): No safety concern based on intake calculated by the MSDI approach of the named compound. 
(e): Data must be available on the substance or closely related substances to perform a safety evaluation. 
(f): Procedure steps, intake estimates, NOAEL, genotoxicity. 
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Table 5:  Summary of safety evaluation by the EFSA/FGE.13Rev2 (EFSA CEF Panel, 2011) 
FL-no EU Register name Structural formula MSDI(a) 
(g/capita per 
day) 
Class(b) 
Evaluation procedure 
path(c) 
Outcome on 
the named 
compound(d),(e) 
Outcome on the 
material of 
commerce(f),(g),(h) 
Evaluation remarks 
13.122 
 
Ethyl 2-furoate O
O
O
 
0.39 
 
Class II 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d f  
13.130 
759 
Furfuryl butyrate 
O
O
O
 
0.24 
 
Class II 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d f  
13.136 
 
2-Furoic acid 
O
OH
O
 
0.013 
 
Class II 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d f  
13.139 
 
5-
Hydroxymethylfurfural
dehyde 
O
OHO
 
0.39 
 
Class II 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d f  
13.145 
 
Methyl 5-
methylfurfuryl sulfide S
O
 
0.0024 
 
Class II 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d f  
13.125 
 
2-Ethyl-5-methylfuran O
 
0.011 
 
Class II 
No evaluation 
  Concern for 
genotoxicity. 
13.155 
 
2-Methyl-5-
propionylfuran O
O
 
0.011 
 
Class II 
No evaluation 
  Concern for 
genotoxicity. 
No longer supported 
by Industry (DG 
SANCO, 2012). 
13.162 
 
2-Octylfuran O
 
0.011 
 
Class II 
No evaluation 
  Concern for 
genotoxicity. 
13.011 
 
Ethyl furfuracrylate 
O
O
O
 
0.12 
 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d f  
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Table 5:  Summary of safety evaluation by the EFSA/FGE.13Rev2 (EFSA CEF Panel, 2011) 
FL-no EU Register name Structural formula MSDI(a) 
(g/capita per 
day) 
Class(b) 
Evaluation procedure 
path(c) 
Outcome on 
the named 
compound(d),(e) 
Outcome on the 
material of 
commerce(f),(g),(h) 
Evaluation remarks 
13.102 
 
Butyl 2-furoate O
O
O
 
0.12 
 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d f  
13.108 
2097 
4,5-Dihydro-3-
mercapto-2-methylfuran 
O
SH  
37 
 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d f  
13.113 
 
2,5-Dimethyl-3-
(methyldithio)furan 
O
S
S
 
0.0012 
 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d f  
13.114 
 
2,5-Dimethyl-3-
(methylthio)furan 
O
S  
0.0024 
 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d f  
13.124 
 
Ethyl furfuryl sulfide 
S
O
 
0.18 
 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d f  
13.127 
 
Furfuryl 2-
methylbutyrate 
O
O
O
 
0.73 
 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d f  
13.129 
 
Furfuryl but-2-enoate O
O
O
 
0.11 
 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d f  
13.132 
 
Furfuryl hexanoate O
O
O
 
0.58 
 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d f  
13.133 
 
Furfuryl isobutyrate 
O
O
O
 
0.89 
 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d f  
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Table 5:  Summary of safety evaluation by the EFSA/FGE.13Rev2 (EFSA CEF Panel, 2011) 
FL-no EU Register name Structural formula MSDI(a) 
(g/capita per 
day) 
Class(b) 
Evaluation procedure 
path(c) 
Outcome on 
the named 
compound(d),(e) 
Outcome on the 
material of 
commerce(f),(g),(h) 
Evaluation remarks 
13.135 
2096 
1-(2-
Furfurylthio)propanone 
O
S
O  
0.61 
 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d f  
13.141 
 
Methyl (2-
furfurylthio)acetate 
O
S
O
O  
0.011 
 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d f  
13.143 
 
Methyl 3-
(furfurylthio)propionate 
O
OS
O
 
0.011 
 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d f  
13.144 
 
Methyl 5-
methylfurfuryl disulfide 
O
S
S
 
0.0024 
 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d f  
13.146 
 
Methyl furfuryl 
trisulfide S
S
S
O
 
0.0024 
 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d f  
13.149 
 
5-Methyl-2-
furanmethanethiol 
O
SH
 
0.37 
 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d f  
13.178 
1524 
3-(Furfuryldithio)-2-
methylfuran 
O
O
S
S
 
0.24 
 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d f  
13.185 
 
2-Furfuryl 3-oxo-2-
butyl disulphide O
S
S
O
 
0.011 
 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d f  
13.199 
2095 
3-[(2-Methyl-3-
furyl)thio]-butanal 
o
s O  
1.2 
 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d f  
(a): EU MSDI: Amount added to food as flavour in (kg / year) x 109 / (0.1 x population in Europe (= 375 x 106) x 0.6 x 365)  =  µg/capita per day. 
(b): Thresholds of concern: Class I = 1800 µg/person per day, Class II = 540 µg/person per day, Class III = 90 µg/person per day. 
(c): Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
(d): No safety concern based on intake calculated by the MSDI approach of the named compound. 
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(e): Data must be available on the substance or closely related substances to perform a safety evaluation. 
(f): No safety concern at the estimated level of intake of the material of commerce meeting the specification requirement (based on intake calculated by the MSDI approach). 
(g): Tentatively regarded as presenting no safety concern (based on intake calculated by the MSDI approach) pending further information on the purity of the material of commerce and/or 
information on stereoisomerism. 
(h): No conclusion can be drawn due to lack of information on the purity of the material of commerce. 
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ABBREVIATIONS 
ALP  Alkaline phosphatase 
CAS  Chemical Abstract Service 
CEF  Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
CoE  Council of Europe 
EFSA  The European Food Safety Authority 
EU  European Union 
FAO  Food and Agriculture Organization of the United Nations  
FEMA  Flavor and Extract Manufacturers Association 
FGE  Flavouring Group Evaluation  
FLAVIS (FL) Flavour Information System (database) 
GLP  Good laboratory practise 
ID  Identity 
IR  Infrared spectroscopy 
JECFA  The Joint FAO/WHO Expert Committee on Food Additives 
MSDI  Maximised Survey-derived Daily Intake 
mTAMDI Modified Theoretical Added Maximum Daily Intake 
No  Number 
NOAEL No observed adverse effect level 
NOEL  No observed effect level 
SCF  Scientific Committee on Food 
WHO  World Health Organization 
